API5 and breast carcinoma: We based our present study on the observation that Api5 is overexpressed in breast cancer and correlated to a poor survival outcome of ERα positive breast cancer patients and on a previous study in which it appeared that the nuclear factor Api5 could be a cofactor of ERα [9].